A0A096NYS4 (A0A096NYS4_PAPAN) Papio anubis (Olive baboon)
RAF proto-oncogene serine/threonine-protein kinase UniProtKBInterProInteractive Modelling
648 aa; Sequence (Fasta) ;
9 identical sequences: Homo sapiens: P04049, L7RRS6; Pongo abelii: Q5R5M7, A0A2J8TVZ9; Theropithecus gelada: A0A8D2FDX4; Macaca nemestrina: A0A2K6DFP8; Macaca mulatta: F6SWC0; Cercocebus atys: A0A2K5MHK1; Nomascus leucogenys: G1QXT4
It is possible new templates exist for this target since these models were created.
Available Structures
44 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Cryo-EM structure of CRaf dimer with 14:3:3 |
Heteromer A0A9R0D7T1; P04049; | |||||
Assess | ||||||
cryo-EM Structure of Craf:14-3-3:Mek1 |
Heteromer A0A9R0D7T1; P04049; Q02750; | 2×29L; | ||||
Assess | ||||||
Structure of the RAF1-HSP90-CDC37 complex (RHC-I) |
Heteromer P04049; P08238; Q16543; | 2×ATP; 2×MG; | ||||
Assess | ||||||
Structure of the RAF1-HSP90-CDC37 complex (RHC-II) |
Heteromer P04049; P08238; Q16543; | 2×ATP; | ||||
Assess | ||||||
Hsp90 provides platform for CRaf dephosphorylation by PP5 |
Heteromer P04049; P08238; P53041; Q16543; | 1×ADP; 2×MG; 2×K; 1×ATP; 2×MN; | ||||
Assess | ||||||
Hsp90 provides platform for CRaf dephosphorylation by PP5 |
Heteromer P04049; P08238; P53041; Q16543; | 2×K; 2×MG; 1×ADP; 1×ATP; 2×MN; | ||||
Assess | ||||||
Cryo-EM structure of the RAF1-HSP90-CDC37 complex in the closed state |
Heteromer A0A7E5VSK5; P04049; Q16543; | 2×ATP; 2×MG; | ||||
Assess | ||||||
Crystal Structure of KRAS-G13D (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cysteine… |
Heteromer P01116; P04049; | 1×GNP; 1×MG; 3×ZN; 2×GOL; 1×CL; | ||||
Assess | ||||||
Crystal Structure of wild-type KRAS (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cys… |
Heteromer P01116; P04049; | 1×GNP; 1×MG; 3×CL; 2×GOL; 1×IPA; 2×ZN; | ||||
Assess | ||||||
Crystal Structure of KRAS-Q61R (GMPPNP-bound) in complex with RAS-binding domain (RBD) and cysteine… |
Heteromer P01116; P04049; | 1×GNP; 1×MG; 3×ZN; 2×GOL; | ||||
Assess | ||||||
Crystal structure of HRas in complex with the Ras-binding and cysteine-rich domains of CRaf-kinase |
Heteromer P01112; P04049; | 1×GNP; 1×MG; 2×ZN; | ||||
Assess | ||||||
Crystal Structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD-CRD) |
Heteromer P01116; P04049; | 1×GNP; 1×MG; 2×ZN; | ||||
Assess | ||||||
NMR data-driven model of KRas-GMPPNP:RBD-CRD complex tethered to a nanodisc (state B) |
Heteromer P01116; P02647; P04049; | 64×PCW; 16×17F; 1×GNP; 1×MG; 2×ZN; | ||||
Assess | ||||||
NMR data-driven model of KRas-GMPPNP:RBD-CRD complex tethered to a nanodisc (state A) |
Heteromer P01116; P02647; P04049; | 64×PCW; 16×17F; 1×GNP; 1×MG; 2×ZN; | ||||
Assess | ||||||
Crystal Structure of wt H-Ras-GppNHp bound to the RBD of Raf Kinase |
Heteromer P01112; P04049; | 1×GNP; 2×CA; 1×MG; 1×ACT; 1×DTU; | ||||
Assess | ||||||
Crystal Structure of wild-type KRAS4b (GMPPNP-bound) in complex with RAS-binding domain (RBD) of RA… |
Heteromer P01116; P04049; | 1×MG; 1×GNP; 3×CL; 2×EDO; 1×MPD; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF RAP.GMPPNP IN COMPLEX WITH THE RAS-BINDING-DOMAIN OF C-RAF1 KINASE (RAFRBD). |
Heteromer P04049; P62834; | 1×MG; 1×GTP; 1×CA; | ||||
Assess | ||||||
Crystal Structure of Q61L H-Ras-GppNHp bound to the RBD of Raf Kinase |
Heteromer P01112; P04049; | 1×GNP; 1×MG; | ||||
Assess | ||||||
Crystal structure of KRAS4a (GMPPNP) in complex with RAF1 (RBD) |
Heteromer P01116; P04049; | 1×MG; 1×GNP; | ||||
Assess | ||||||
Complex of Rap1A(E30D/K31E)GDP with RafRBD(A85K/N71R) |
Heteromer P04049; P62834; | 1×GDP; 1×MG; 1×CA; | ||||
Assess | ||||||
HUMAN RAP1A, RESIDUES 1-167, DOUBLE MUTANT (E30D,K31E) COMPLEXED WITH GPPNHP AND THE RAS-BINDING-DO… |
Heteromer P04049; P62834; | 1×MG; 1×GNP; 1×CA; | ||||
Assess | ||||||
Crystal Structure of KRAS4b-G13D (GMPPNP-bound) in complex with RAS-binding domain (RBD) of RAF1/CR… |
Heteromer P01116; P04049; | 1×GNP; 1×MG; | ||||
Assess | ||||||
Complex of Ras-GDP with RafRBD(A85K) |
Heteromer P01112; P04049; | 1×GDP; 1×MG; | ||||
Assess | ||||||
Crystal Structure of G12V HRas-GppNHp bound in complex with the engineered RBD variant 1 of CRAF Ki… |
Heteromer P01112; P04049; | 1×GNP; 1×GOL; 1×MG; | ||||
Assess | ||||||
Crystal Structure of G12V HRas-GppNHp bound in complex with the engineered RBD variant 12 of CRAF K… |
Heteromer P01112; P04049; | 1×MG; 1×GNP; | ||||
Assess | ||||||
14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide |
Heteromer P04049; P63104; | |||||
Assess | ||||||
Human 14-3-3 isoform zeta in complex with a diphoyphorylated C-RAF peptide and Cotylenin A |
Heteromer P04049; P63104; | 2×K; 2×1F5; | ||||
Assess | ||||||
Small molecule stabilizer (compound 8) for C-RAF and 14-3-3 |
Heteromer P04049; P31947; | 2×CL; 4×MG; 2×O56; | ||||
Assess | ||||||
Small molecule stabilizer (compound 7) for C-RAF and 14-3-3 |
Heteromer P04049; P31947; | 2×CL; 4×MG; 2×L6L; | ||||
Assess | ||||||
Small molecular stabilizer for C-RAF (pS259) and 14-3-3 (1075306) |
Heteromer P04049; P31947; | 2×CL; 6×MG; 2×O5I; | ||||
Assess | ||||||
Small molecule stabilizer (compound 5) for C-RAF(pS259) and 14-3-3 |
Heteromer P04049; P31947; | 6×MG; 2×L7U; | ||||
Assess | ||||||
Small molecular stabilizer for C-RAF (pS259) and 14-3-3 (1075297) |
Heteromer P04049; P31947; | 2×CL; 4×MG; 2×O6L; | ||||
Assess | ||||||
Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome |
Heteromer P04049; P63104; | 2×MG; 1×PPI; | ||||
Assess | ||||||
Impaired binding of 14-3-3 to Raf1 is linked to Noonan and LEOPARD syndrome |
Heteromer P04049; P63104; | 1×PPI; | ||||
Assess | ||||||
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (10mer) |
Heteromer P04049; P31947; | 2×CL; 6×MG; | ||||
Assess | ||||||
small molecule stabilizer (compound 1) for C-RAF pS259 and 14-3-3 |
Heteromer P04049; P31947; | 2×CL; 6×MG; 2×O6C; | ||||
Assess | ||||||
14-3-3 isoform sigma in complex with a phosphorylated C-RAF peptide |
Heteromer P04049; P31947; | |||||
Assess | ||||||
Structure of 14-3-3 isoform sigma in complex with a C-Raf1 peptide and a stabilizing small molecule… |
Heteromer P04049; P31947; | 2×M1T; | ||||
Assess | ||||||
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) |
Heteromer P04049; P31947; | 2×CL; 6×MG; | ||||
Assess | ||||||
Crystal Structure of human 14-3-3 sigma in Complex with Raf1 peptide (6mer) and stabilisator Fusico… |
Heteromer P04049; P31947; | 2×FSC; 4×CL; 8×MG; | ||||
Assess | ||||||
Crystal structure of c-raf (raf-1) | homo-2-mer | 2×SM5; | ||||
Assess | ||||||
NMR SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF C-RAF-1 | monomer | |||||
Assess | ||||||
RAF-1 CYSTEINE RICH DOMAIN, NMR, 27 STRUCTURES | monomer | 2×ZN; | ||||
Assess | ||||||
RAF-1 CYSTEINE RICH DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE | monomer | 2×ZN; | ||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8dgs.1.A | monomer | 0.58 | 1×AGS; 2×ZN; | 63.60 | ||
Assess | ||||||
7z38.1.C | monomer | 0.55 | 99.69 | |||
Assess |